Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04828083

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

Conditions: Arthroplasty, Replacement, Knee, Total Knee Arthroplasty

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 120

Sponsor: Rhode Island Hospital

Location: Rhode Island Hospital Providence Rhode Island

Summary

The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.

Eligibility Criteria

Inclusion Criteria: * ASA PS 1-3 patients undergoing primary, unilateral total knee arthroplasty Exclusion Criteria: * ASA PS classification of 4 or greater * Pre-existing neuropathy * Coagulopathy * Chronic opioid consumption (\>3 months) * Infection at the site * Known allergy to study medications (lidocaine) * High grade atrioventricular block (cardiac conduction system impairment) * A history of CVA/TIA * Currently using lidocaine patches * Known liver disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04828083). StuddyBuddy aggregates publicly available trial information.